FDA Drug recall D-0553-2026
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal W…
- FDA Drug
- Class I
- ongoing
- Published 2026-05-27
On 2026-05-27 the FDA classified a Class I recall of MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal W… by Wisconsin Pharmacal, citing microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0553-2026 |
| Classification | Class I |
| Status | ongoing |
| Initiated | 2026-04-24 |
| Published | 2026-05-27 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Wisconsin Pharmacal |
| Distribution | US |
Product
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Reason
Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
Identifiers
| code_info | Lot #: 1024088, Exp 11/30/2026 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0553-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.